DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma

BACKGROUND: Deoxycytidine kinase (DCK), an enzyme in the nucleoside biosynthetic pathway, can affect the development of immune cells. However, the relationships between the expression of DCK, patient prognosis, and tumor-infiltrating immune cells (TIICs) in hepatocellular carcinoma (HCC) are still u...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Surg Oncol
Asıl Yazarlar: Song, Danjun, Wang, Yining, Zhu, Kai, Tian, Lingyu, Gao, Qiang, Zhou, Jian, Fan, Jia, Wang, Xiaoying
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372783/
https://ncbi.nlm.nih.gov/pubmed/32690026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01953-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller